tazemetostat,bvd-523
epizyme,eisai pharmaceutical
['match study', 'tazemetostat']
in today's #asco22 poster discussion session on #pediatriconcology, see results of -pediatric match study using tazemetostat to treat patients with relapsed tumors. 12:30 pm et, 
National #biomedical #research resource w/ focus on #cancer, #AIDS, & #infectious diseases. Currently operated by Leidos Biomedical Research for @theNCI.